investigator_user
investigator
user
funding
collaborators
pending
menu
bell
message
arrow_up
arrow_down
filter
layers
globe
marker
add
arrow
close
download
edit
facebook
info
linkedin
minus
plus
save
share
search
sort
twitter
remove
user-plus
user-minus
Sign Up for Updates
Map
Countries
Cancer types
All cancers but non-melanoma skin cancer
Bladder
Brain, nervous system
Breast
Cervix uteri
Colorectum
Corpus uteri
Gallbladder
Hodgkin lymphoma
Kaposi sarcoma
Kidney, renal pelvis and ureter
Larynx
Leukaemia
Lip, oral cavity
Liver and intrahepatic bile ducts
Melanoma of skin
Multiple myeloma and immunoproliferative diseases
Nasopharynx
Non-Hodgkin lymphoma
Non-Melanoma skin cancer
Oesophagus
Other pharynx
Ovary
Pancreas
Prostate
Sarcoma
Stomach
Testis
Thymus
Thyroid
Trachea, bronchus and lung
Specialities
Hematology and hematologic malignancies
Palliative Care
Pathology
Pediatric oncology or childhood cancer
Radiation Oncology
Surgery / Surgical oncology
Blog
About
Login
Project leads
Collaborators
Shared Genomic Segment Analysis and Tumor Subtyping in High-Risk BrCa Pedigrees
Nicola J Camp
1 Collaborator(s)
Funding source
National Cancer Institute (NIH)
Follow
+ Project
+ Post
+ Event
Info
People
Posts
Angela Cox
University of Sheffield
Sheffield, United Kingdom
Nicola J Camp
University of Utah
Salt Lake City, United States
Related projects
Global Noncommunicable Diseases Intiatives
Project for prevention and intervention on childhood, youth, disability and sanitation. Development and implementation of activities.
Breast
Rulla M Tamimi
Mammographic density and texture features in relation to breast cancer risk
Breast
Pathology
Charles D Blanke
SWOG Community Clinical Oncology Program Research Base
Breast
John J Heine
Automated Quantitative Measures of Breast Density
Breast
Melissa L Bondy
Risk Prediction for ER Negative Breast Cancer Recurrence
Breast
Global Noncommunicable Diseases Intiatives
Support program in the fight against cancer - Experts fund
Breast
Ricardo Alvarez
Pilot Study of Prognostic Utility of Circulating Tumor Cells (CTCs) Assed by Adnagen Technology and Clinical Outcome of Patients with Stage II Breast Cancer who Completed Locoregional and Systematic Treatment
Breast
Global Noncommunicable Diseases Intiatives
Mammography Installation Project
Breast
David J Hunter
Discovery, Biology and Risk of Inherited Variants in Breast Cancer
Breast
